Mounjaro for Type 2 Diabetes: How It Compares to Other Treatments in the UK
A comprehensive guide to using Mounjaro (tirzepatide) for type 2 diabetes management in the UK—how it works, when it's prescribed, and how it compares to insulin, metformin, and other medications.
A New Era in Type 2 Diabetes Care
Mounjaro (tirzepatide) was originally developed as a type 2 diabetes medication—and it's transforming how we treat this chronic condition. Approved in the UK for diabetes management since 2022, Mounjaro offers something previous medications couldn't: powerful blood sugar control combined with significant weight loss.
For the millions of people in the UK living with type 2 diabetes, this dual benefit addresses two core problems at once. Poor blood sugar control damages organs over time, whilst excess weight makes diabetes harder to manage and contributes to complications. Mounjaro tackles both simultaneously.
But where does it fit in the UK's diabetes treatment landscape? When might your GP or diabetes specialist consider prescribing it? And how does it compare to the medications you might already be taking?
How Effective Is Mounjaro for Blood Sugar Control?
The clinical evidence for Mounjaro in type 2 diabetes is remarkable. Let's look at the numbers:
In the SURPASS clinical trial programme, Mounjaro consistently delivered superior HbA1c reductions compared to placebo, other GLP-1 medications, and even insulin. Many participants achieved HbA1c levels in the non-diabetic range (below 5.7%)—something previously rare with medication alone.
💡 What is HbA1c? HbA1c (glycated haemoglobin) measures your average blood sugar over the past 2-3 months. It's the key marker doctors use to assess diabetes control. In the UK, targets are typically <7% (53 mmol/mol) for most people with diabetes, though individual targets vary.
The Weight Loss Advantage
What makes Mounjaro uniquely powerful for diabetics is the weight loss it produces. In trials, people with type 2 diabetes lost an average of 7-11kg depending on the dose used. This weight reduction:
When Is Mounjaro Prescribed? UK Guidelines Explained
Mounjaro isn't typically a first-line treatment for type 2 diabetes in the UK. NICE (National Institute for Health and Care Excellence) and Diabetes UK recommend a stepped approach:
Typical UK Diabetes Treatment Pathway
Diagnosis & Lifestyle Changes
Diet modification, weight loss, exercise. May be enough for some newly diagnosed patients with mild diabetes.
First-Line Medication: Metformin
Usually started if lifestyle changes don't achieve targets. Metformin is cheap, effective, and well-tolerated for most people.
Second-Line: Combination Therapy
If metformin alone isn't enough, additional drugs are added: sulphonylureas, DPP-4 inhibitors, SGLT2 inhibitors, or GLP-1s.
Mounjaro Considered Here
When dual or triple therapy isn't controlling HbA1c adequately, or if significant weight loss is needed alongside diabetes control.
Insulin Therapy
Traditionally the next step if oral meds fail. Mounjaro may delay or prevent the need for insulin in many patients.
NHS Eligibility for Mounjaro (Type 2 Diabetes)
As of 2025, Mounjaro can be prescribed on the NHS for type 2 diabetes when:
- HbA1c remains above target despite trying metformin plus at least one other diabetes medication
- BMI is ≥35 kg/m² (or ≥32.5 kg/m² for people of South Asian, Chinese, Black African, or African-Caribbean family origin)
- The patient would otherwise require insulin or another injectable treatment
Some specialist diabetes centres may prescribe it under slightly different criteria. Your diabetes team will assess whether you meet the requirements.
⚠️ Important note: NHS availability varies by region and GP practice. Some areas have stricter criteria or waiting lists due to budget constraints. If you don't qualify for NHS provision but want to try Mounjaro, private prescriptions are available through online clinics and private GPs.
Mounjaro vs Other Diabetes Medications
Let's compare Mounjaro to the main alternatives you might encounter:
Mounjaro vs Metformin (and other oral diabetes drugs)
| Factor | Metformin | Mounjaro |
|---|---|---|
| How it works | Reduces glucose production in liver, improves insulin sensitivity | Mimics GLP-1 & GIP hormones; reduces appetite, slows digestion, stimulates insulin |
| HbA1c reduction | ~1.0-1.5% | ~2.0-2.4% |
| Weight effect | Weight neutral or minor loss (1-2kg) | Significant loss (7-11kg average) |
| Dosing | Tablets, 1-3 times daily | Weekly injection |
| Common side effects | Stomach upset, diarrhoea (usually temporary) | Nausea, reduced appetite (usually temporary) |
| NHS cost | Very cheap (pennies per day) | Expensive (~£150-200/month), restricted access |
Bottom line: Metformin remains the foundation of type 2 diabetes treatment—it's effective, safe, and cheap. Mounjaro is far more powerful but reserved for those needing stronger intervention, particularly if weight is a major factor.
Mounjaro vs Insulin
For many years, insulin was the inevitable next step when oral medications failed. Mounjaro offers a compelling alternative:
| Factor | Insulin Therapy | Mounjaro |
|---|---|---|
| Blood sugar control | Excellent (can achieve any target with enough insulin) | Excellent (~80% reach HbA1c <7%) |
| Weight effect | Often causes weight GAIN (2-4kg typical) | Significant weight LOSS (7-11kg) |
| Hypoglycaemia risk | Moderate to high (depends on type and dose) | Very low (unless combined with sulphonylureas or insulin) |
| Dosing complexity | May require multiple daily injections, dose adjustments with meals/activity | Once weekly, fixed dose |
| Patient acceptance | Often feared/resisted ("insulin means my diabetes is severe") | Generally well-accepted, especially given weight loss |
🩺 Clinical insight: For many patients with type 2 diabetes and obesity, Mounjaro can delay or eliminate the need for insulin therapy. By tackling both high blood sugar and excess weight, it addresses root causes rather than just symptoms. Some patients who were already on insulin have been able to reduce or stop it after starting Mounjaro (under medical supervision).
Mounjaro vs Other GLP-1 Medications (e.g. Ozempic)
Several GLP-1 receptor agonists are available for diabetes. How does Mounjaro compare?
| Medication | Active Ingredient | Mechanism | HbA1c Reduction | Weight Loss |
|---|---|---|---|---|
| Ozempic | Semaglutide | GLP-1 agonist only | ~1.5-1.8% | ~5-7kg |
| Trulicity | Dulaglutide | GLP-1 agonist only | ~1.4-1.6% | ~3-4kg |
| Victoza | Liraglutide | GLP-1 agonist only (daily) | ~1.1-1.5% | ~2-3kg |
| Mounjaro | Tirzepatide | GLP-1 + GIP dual agonist | ~2.0-2.4% | ~7-11kg |
Key differences:
- Mounjaro's dual mechanism (targeting both GLP-1 and GIP receptors) generally produces better results than single GLP-1 agonists
- Head-to-head trials (SURPASS-2) showed Mounjaro superior to Ozempic for both HbA1c reduction and weight loss
- Side effect profiles are similar across GLP-1 drugs—mainly GI issues like nausea, which improve over time
- All are once-weekly injections (except Victoza which is daily)
- NHS access varies—Ozempic and Trulicity have been available longer and may be more readily prescribed in some areas
Accessing Mounjaro for Diabetes in the UK
NHS Route
If you meet the eligibility criteria mentioned earlier, speak to your GP or diabetes specialist. They'll assess whether Mounjaro is appropriate and can prescribe it on the NHS if you qualify. Be aware there may be waiting lists or prior authorisation requirements depending on your local ICB (Integrated Care Board).
Private Prescription
If you don't qualify for NHS provision—or face long waits—you can obtain Mounjaro privately. Options include:
- Private GPs and diabetes clinics
- Online telehealth services (after medical consultation)
- Private hospitals with endocrinology departments
Expect to pay £200-350+ per month depending on your dose. Most private providers include the initial consultation in their service.
Compare Mounjaro Providers & Prices
Finding the right provider at the best price can save you hundreds of pounds. Our comparison tool shows vetted UK pharmacies and clinics offering Mounjaro for diabetes.
Jaro Compare NowKey Benefits and Considerations
Why Choose Mounjaro for Type 2 Diabetes?
- Dual benefit: Excellent blood sugar control PLUS significant weight loss
- Once weekly: More convenient than daily medications or multiple insulin injections
- Low hypo risk: Unlike insulin or sulphonylureas, it won't cause dangerous low blood sugars when used alone
- Cardiovascular benefits: Weight loss and metabolic improvements likely reduce heart disease risk (cardiovascular outcome trials ongoing)
- May reverse diabetes: Some patients achieve remission (HbA1c in non-diabetic range without medication)
Important Considerations
- Side effects: Nausea, vomiting, diarrhoea, and reduced appetite are common initially. Usually improve after a few weeks
- Cost: Expensive if paying privately
- Injections: Requires self-injection (though the pen device is easy to use)
- Long-term use: Like most diabetes medications, Mounjaro typically needs to be continued long-term. Stopping often leads to blood sugar rising and weight regain
- Medical supervision required: Regular monitoring of HbA1c, weight, and side effects is essential
⚠️ Contraindications: Mounjaro is not suitable if you have a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2. It's also not recommended in pregnancy or if you have severe gastrointestinal disease. Always discuss your full medical history with your prescribing doctor.
The Bottom Line
Mounjaro represents a significant advancement in type 2 diabetes treatment. Its dual-action mechanism delivers superior blood sugar control and substantial weight loss—addressing two core problems simultaneously.
For people with type 2 diabetes who are struggling to reach their HbA1c targets despite multiple medications, or who carry significant excess weight, Mounjaro offers genuine hope. It may delay or prevent the need for insulin, improve quality of life, and reduce the risk of diabetes complications.
However, it's not for everyone. Your doctor will consider your individual circumstances—current medications, weight, kidney function, other health conditions, and personal preferences—to determine if Mounjaro is the right choice for you.
If you're interested in exploring Mounjaro as a treatment option, start the conversation with your GP or diabetes specialist. Come prepared with questions, and be honest about your struggles with current treatments. Together, you can decide if this powerful new medication has a place in your diabetes management plan.
⚠️ Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Mounjaro is a prescription-only medication in the UK. Always consult with a qualified healthcare professional before starting, stopping, or changing any diabetes treatment. Individual results vary. Monitor blood sugar levels as directed by your healthcare team. This content has not been evaluated by the MHRA or Diabetes UK.